Capecitabine Mylan 500 mg Filmdragerad tablett

Valsts: Zviedrija

Valoda: zviedru

Klimata pārmaiņas: Läkemedelsverket (Medical Products Agency)

Aktīvā sastāvdaļa:

kapecitabin

Pieejams no:

Mylan S.A.S.

ATĶ kods:

L01BC06

SNN (starptautisko nepatentēto nosaukumu):

capecitabine

Deva:

500 mg

Zāļu forma:

Filmdragerad tablett

Kompozīcija:

kapecitabin 500 mg Aktiv substans

Klase:

Apotek

Receptes veids:

Receptbelagt

Ārstniecības joma:

Kapecitabin

Autorizācija statuss:

Avregistrerad

Autorizācija datums:

2012-11-16

Lietošanas instrukcija

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CAPECITABINE MYLAN 150 MG FILM-COATED TABLETS
CAPECITABINE MYLAN 500 MG FILM-COATED TABLETS
capecitabine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Capecitabine Mylan is and what it is used for
2.
What you need to know before you take Capecitabine Mylan
3.
How to take Capecitabine Mylan
4.
Possible side effects
5.
How to store Capecitabine Mylan
6.
Contents of the pack and other information
1.
WHAT CAPECITABINE MYLAN IS AND WHAT IT IS USED FOR
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 150 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 500 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan is used in the treatment of colon, rectal, gastric,
or breast cancers.
Furthermore, Capecitabine Mylan is used to prevent new occurrence of
colon cancer after complete
removal of the tumour by surgery.
Capecitabine Mylan may be used either alone or in combination with
other medicines.
2.
WHAT Y

Produkta apraksts

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_